Polymorphisms of IFNL3 and Response to Interferon-Based Treatments in Patients with Hepatitis D Infection: Systematic Review and Meta-Analysis
نویسندگان
1 Middle East Liver Disease (MELD) Center, Tehran, IR Iran
2 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
3 Bacteriology and Virology Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
doi
10.5812/ircmj.64392چکیده
The hepatitis D virus (HDV) is a RNA virus that needs the hepatitis B virus (HBV) surface antigen (HBsAg) to complete its life cycle (1). HDV has a worldwide distribution; the infection is endemic in the Middle East, Mediterranean countries, Central Africa, and northern parts of South America (2).
